🔎 Trials Near Me

Pradžia › Aterosklerozė › Luiziana

Aterosklerozė klinikiniai tyrimai Luiziana

6 tyrimai dėl Aterosklerozė ieško dalyvių vietose Luiziana.

Oficialus tyrimo tekstas (anglų kalba)

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Tulane University School of Medicine, New Orleans
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Cardiovascular Associates Research, LLC, Covington
  • Tandem Clinical Research - Marrero, Marrero
Renkami dalyviai3 fazė
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Renal Associates of Baton Rouge, Baton Rouge
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Covington
  • Research Site, Hammond
  • Research Site, Lake Charles
  • ir dar 4
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-24 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

  • Omega Clinical Research, Metairie
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06813911

Pelacarsen Roll-over Extension Program

  • Cardiovascular Associates Research, Covington
  • Omega Clinical Research, Metairie
  • CV Ins of the South, Opelousas
  • ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06875973

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.